In reply: Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: Is it time to change the Canadian guidelines?
Standards Committee, Canadian Anesthesiologists' Society, Toronto, ON, Canada. G.Dobson@Dal.Ca.
Gregory
G
Dobson
Standards Committee, Canadian Anesthesiologists' Society, Toronto, ON, Canada.
Richard N
RN
Merchant
D002170:Canada; D006801:Humans; D019148:Neuromuscular Blockade; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use; D061886:Neuromuscular Monitoring
D009466:Neuromuscular Blocking Agents